# Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin

> **NCT00907426** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 368 (actual)

## Conditions studied

- Hypotrichosis

## Interventions

- **DRUG:** Bimatoprost 0.03% solution
- **DRUG:** Vehicle solution

## Key facts

- **NCT ID:** NCT00907426
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-11
- **Final completion:** 2011-05
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2012-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907426, "Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00907426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*